一年两针的抗艾长效药来了!感染率降低96%

第一财经
13 Sep 2024

当地时间9月12日,吉利德再公布一项大型三期临床研究表明,一年注射两次的长效艾滋病预防药物利那卡韦(Lenacapavir)使艾滋病毒(HIV)感染率降低96%。就在三个月前,吉利德公布了Lenacapavir注射液的首个大型临床研究数据,称该药物在女性艾滋病毒暴露前预防(PrEP)的有效率达到100%。业内认为,这些数据为FDA批准该药物用于预防艾滋病奠定基础。积极的三期试验数据推动了吉利德的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10